The space contractor’s stock clawed back some ground on Wednesday, rising 2.30 percent to €62.20 in European trading after closing at €60.80 the prior session. The modest gain follows a brutal stretch that wiped nearly 30 percent off the share price over the past month, leaving the stock trading roughly 54 percent below its 52-week high of €133.80 reached on May 27.
The catalyst for the bounce came from the Pentagon. On July 21, the U.S. Air Force awarded Rocket Lab a fixed-price contract valued at $266 million for suborbital launch services. The deal covers 12 launches of suborbital rockets from the Pacific Spaceport Complex in Alaska, with options for six additional missions. Work is scheduled for completion by December 31, 2028, and approximately $112 million of the funding comes from fiscal year 2025 research appropriations. The contract number FA8818-26-C-B003 was issued through the Space Systems Command at Kirtland Air Force Base following a competitive process that drew three bids.
The announcement initially sparked a more dramatic reaction in after-hours trading, where RKLB shares jumped as much as 9 percent, touching prices between $73.19 and $73.45 on various exchanges. That followed a regular session that had already seen the stock gain over 5 percent. On a euro-denominated basis, Tuesday’s close of €60.70 represented a 5.75 percent advance from the prior day.
A Sector-Wide Tailwind
The Air Force contract arrives on the heels of an even larger development for the broader space industry. On July 17, the Space Force raised the ceiling on its “National Security Space Launch Phase 3 Lane 1” contract from $5.6 billion to $17 billion, freeing up significantly more defense department budget for launch contracts through fiscal year 2029. Seven companies are competing for those awards: SpaceX, United Launch Alliance, Blue Origin, Rocket Lab, Stoke Space, Impulse Space, and Relativity Space. The expanded pool benefits all participants, and Rocket Lab’s established position within that group gives it a natural advantage.
Retail investors appear to be treating the news flow as a buying opportunity rather than a warning signal. On Stocktwits, sentiment around the RKLB ticker remained “bullish” despite elevated news volume.
The Iridium Overhang
For all the positive contract momentum, the market’s attention is increasingly consumed by Rocket Lab’s planned $8 billion acquisition of satellite operator Iridium Communications, announced in late June. The company has offered $54 per share for Iridium, representing a roughly 60 percent premium over Iridium’s market capitalization of $5.01 billion. Management frames the deal as a step toward becoming a fully vertically integrated space company — spanning rocket launches, satellite manufacturing, and in-orbit communications.
Should investors sell immediately? Or is it worth buying Rocket Lab?
But the acquisition ambition has stoked concerns about potential share dilution to finance the transaction. Those worries have been compounded by insider selling activity totaling $362.8 million over the past three months, with no corresponding insider purchases. A portion of those sales came from CEO Peter Beck, who disposed of shares in early July at prices between roughly $82 and $102. Beck’s sales were reportedly executed under a pre-arranged 10b5-1 trading plan, which is typically insulated from current insider knowledge — a detail that tempers the alarm that raw selling figures might otherwise trigger.
Neutron Delays Add to the Uncertainty
Adding to the strategic questions, Rocket Lab’s Neutron rocket has been delayed. After a failed tank test, the vehicle is now expected to launch in the fourth quarter of 2026 rather than earlier. Observers view the upcoming Neutron test stands as a critical operational proof point for whether the company can execute on its ambitions.
The company’s operational fundamentals remain solid. First-quarter revenue hit a record $200.35 million, up 63.5 percent year-over-year. The backlog stands at $2.2 billion, and liquidity exceeds $2 billion. The Electron rocket has now completed more than 90 missions, deploying 262 satellites, and Rocket Lab ranks as the second-most active U.S. launch provider.
Analyst Divergence and Technical Signals
Wall Street remains split on the stock. The consensus rating is “Moderate Buy” with an average price target of $110.18, implying roughly 60 percent upside from recent levels. Piper Sandler struck a more cautious tone, initiating coverage with “Neutral” and a price target of $83.
The technical picture reflects the market’s skittishness. The 14-day relative strength index sits at 33.7 in U.S. trading and 35.6 on the European side — both readings in oversold territory, suggesting the recent downward pressure may have been overdone. The annualized 30-day volatility of roughly 93 percent underscores just how jittery trading in the name has become.
On a year-to-date basis, the stock is down about 1.3 percent, masking the violent swings of recent months. Over the trailing twelve months, the gain still exceeds 55 percent — a reminder that the long-term trajectory remains positive even as short-term turbulence persists. With the Iridium deal, Neutron delays, and a steady stream of defense contracts all competing for investor attention, that volatility looks set to continue.
Ad
Rocket Lab Stock: Buy or Sell?! New Rocket Lab Analysis from July 22 delivers the answer:
The latest Rocket Lab figures speak for themselves: Urgent action needed for Rocket Lab investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 22.
Rocket Lab: Buy or sell? Read more here...
